产品详情;
CasNo： 115956-13-3
外观： Colorless liquid
交货时间： In stock
生产能力： 10000|Metric Ton|Month
技术指标： 99%
| Description | Dolasetron was launched as Anzemet in Australia and the US for the prevention of nausea and vomiting in chemotherapy patients. It is a highly potent and very selective antagonist of 5-HT3 receptors ; it is the sixth in this class of compounds to be marketed for the treatment of chemotherapy-induced emesis. The last two approved in this class were Nazasetron (1994) and Ramosetron (1996). Anzemet was prepared by a seven step sequence from a cyclopentenecarboxylic ester via a Robinson-Schopf cyclisation of a dialdehyde into a key 9-azabicyclo[3.3.l]nonan-3-one. In a clinical study with 164 cancer patients treated with Dolasetron mesylate prior to Cisplatin, single doses of 10- 50 mg achieved major control of nausea and emesis in 73% of subjects and were well tolerated. Results from pharmacokinetic studies in humans showed that the clinical effects and duration of action seem to be due mainly to a major plasma metabolite rapidly formed and very potent itself, the (+) enantiomeric alcohol obtained by enzymatic reduction of the cyclic ketone. |
| Originator | Hoechst Marion Roussel (Germany) |
| Uses | Nausea in chemotherapy;5-HT3 antagonist |
| Uses | Antidepressant |
| Uses | Dolasetron Mesylate acts as a bridged pseudopelletierine derivative; specific serotonin (5HT3) receptor antagonist. Antiemetic. |
| Brand name | Anzemet (Sanofi Aventis. |
| Veterinary Drugs and Treatments | Dolasetron may be effective in treating severe nausea and vomiting in dogs and cats, particularly if caused by cancer chemotherapy drugs. Because it is given once a day, the injectable form of dolasetron is often preferred over ondansetron, a similarly effective antiemetic. However, for oral use in small animals, dolasetron tablets are too large (50 and 100 mg) to be practically administered. |
相关产品
-
4-氰基-3-氟苯硼酸CAS：843663-18-3
-
烯丙基三丁基锡CAS：24850-33-7
-
4-(2,6,6-三甲基环己基)-3-甲基-2-丁醇CAS：60241-53-4
-
5-苄氧基吲哚-3-甲醛CAS：6953-22-6
